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Androgens are key regulators of male sexual
differentiation during the in utero and early
postnatal development. Exposure to chemi-
cals that counteract androgen action at some
stage in this period can permanently demas-
culinize male fetuses and lead to malforma-
tions of the reproductive tract. Examples of
chemicals known to disrupt sexual differenti-
ation in this way include pesticides and their
metabolites, such as vinclozolin, procymi-
done, 1,1-dichloro-2,2-bis(4-chlorophenyl)
ethylene (p,p´-DDE), and linuron, and cer-
tain phthalate esters such as di-ethylhexyl
phthalate and di-butyl phthalate (Gray et al.
2000, 2001). Reduced anogenital distance,
retention of nipples or areolas, hypospadias,
agenesis of sex accessory tissues, and unde-
scended testes have been described as conse-
quences of disruption of androgen action in
the developing rat. These effects are thought
to arise through antagonism of androgens at
the steroid receptor level and/or via suppres-
sion of testosterone synthesis in Leydig cells
(Fisher 2004; Gray et al. 2001).
Many anti-androgenic chemicals have
been found as mixtures in humans (Blount
et al. 2000; Swan et al. 2005), including chil-
dren (Brock et al. 2002; Main et al. 2006),
and in wildlife (Guillette 2000). These ﬁnd-
ings have stimulated interest in exploring the
consequences of combined exposures to anti-
androgens, although relatively few studies
have addressed the issue. There is good evi-
dence that inhibition of androgen binding
and other receptor-mediated events occur in
an additive fashion (Birkhoj et al. 2004; Gray
et al. 2001; Nellemann et al. 2003), but little
is known about the developmental effects of
in utero and early postnatal exposure to multi-
ple anti-androgenic chemicals.
In this article, we present data from
detailed investigations of the ability of combi-
nations of androgen receptor (AR) antagonists
to induce disruption of male sexual differenti-
ation after long-term exposures in utero and
postnatally. We selected a mixture of vinclo-
zolin, procymidone, and flutamide for our
experiments. Vinclozolin metabolites compete
with androgens for AR binding (Kelce et al.
1994), suppress androgen-dependent gene
transcription (Kelce et al. 1997), and affect
reproductive development. Procymidone and
flutamide also antagonize competitively the
AR binding of androgens, with consequent
inhibition of AR-mediated gene expression
(Ostby et al. 1999; Simard et al. 1986).
Common developmental effects of all three
chemicals after in utero exposure of male rats
include reduced anogenital distance (AGD),
nipple retention (NR), hypospadia, dimin-
ished prostate weight, reduced testis and epi-
didymal weights, and altered behavior in male
offspring (Foster and McIntyre 2002; Gray
et al. 1994; Hellwig et al. 2000; Hib and
Ponzio 1995; Hotchkiss et al. 2002; McIntyre
et al. 2001; Miyata et al. 2002; Ostby et al.
1999; Shimamura et al. 2002). There is no
particular environmental relevance to this
mixture. The choice of compounds was moti-
vated by our interest to explore the pre-
dictability of combination effects caused by
similarly acting anti-androgens rather than to
emulate “real world” mixtures.
Conclusive answers to the question of
combination effect predictability require
quantitative comparisons between predicted
and experimentally observed mixture effects.
Experimentally, we have approached this task
in a step-wise fashion: a) Dose–response
curves for all single-mixture components were
recorded. b) These data were used for the cal-
culation of additivity expectations for a mix-
ture of specific composition using “fixed
mixture ratio design” (Altenburger et al.
2000; Hewlett and Plackett 1959). c) The
mixture experiments were conducted. d) The
observed combination effects were compared
with the predicted responses.
The choice of an appropriate model for
the calculation of additivity expectations is
essential for assessments of mixture effects
because it is in relation to these additivity
expectations that combination effects are
judged in terms of synergisms or antago-
nisms. Several concepts for the computation
of expected additive effects of anti-androgens
have been used. The simple method of sum-
ming the individual effects of chemicals in
the combination, termed “effect summation,”
has been drawn on previously (Gray et al.
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OBJECTIVE: The aim of this study was to assess whether the joint effects of three androgen receptor
antagonists (vinclozolin, ﬂutamide, procymidone) on male sexual differentiation after in utero and
postnatal exposures can be predicted based on dose–response data of the individual chemicals. 
METHODS: Test chemicals and mixtures were administered by gavage to time-mated nulliparous,
young adult Wistar rats from gestational day 7 to the day before expected birth, and from postnatal
days 1–16. Changes in anogenital distance (AGD) and nipple retention (NR) in male offspring rats
were chosen as end points for extensive dose–response studies. Vinclozolin, flutamide, and pro-
cymidone were combined at a mixture ratio proportional to their individual potencies for causing
retention of six nipples in male offspring. 
RESULTS: With AGD as the end point, the joint effects of the three anti-androgens were essentially
dose additive. The observed responses for NR were slightly higher than those expected on the basis of
dose addition. A combination of doses of each chemical, which on its own did not produce statistically
signiﬁcant AGD alterations, induced half-maximal mixture effects. At individual doses associated with
only modest effects on NR, the mixture induced NR approaching female values in the males. 
CONCLUSIONS: Effects of a mixture of similarly acting anti-androgens can be predicted fairly accu-
rately on the basis of the potency of the individual mixture components by using the dose addition
concept. Exposure to anti-androgens, which individually appears to exert only small effects, may
induce marked responses in concert with, possibly unrecognized, similarly acting chemicals.
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sigmoidal dose–response curves (Kortenkamp
and Altenburger 1998). The concept of dose
addition, also referred to as “concentration
addition” (Loewe and Muischnek 1926), is
usually employed for combinations of chemi-
cals with similar modes of action. It has previ-
ously given additivity expectations well in
agreement with experimental observations for
inhibition of AR binding and AR-mediated
responses in vitro and in vivo (Birkhoj et al.
2004; Nellemann et al. 2003). In light of
these observations, we reasoned that dose
addition would also produce valid additivity
expectations for developmental effects after
prolonged in utero and postnatal exposures.
Although a series of articles have been
published describing the successful applica-
tion of the fixed mixture ratio approach to
in vitro systems (Altenburger et al. 2000;
Backhaus et al. 2000; Payne et al. 2001;
Rajapakse et al. 2002, 2004; Silva et al.
2002), there is comparatively little experience
with in vivo assays. In the endocrine disruptor
field, Brian et al. (2005) have recently
demonstrated the usefulness of this method to
the assessment of multicomponent mixtures
of estrogenic chemicals in fish, but there are
as yet no examples with mammalian assays
in vivo. Thus, to make the assessment of
developmental effects of mixtures of chemi-
cals a viable proposition, a number of practi-
cal requirements had to be considered. Of
particular importance were demands of mini-
mal data variation and high reproducibility.
When dealing with several mixture compo-
nents and a large number of dose levels, the
parallel testing of all agents and their mixtures
is not a realistic option, especially not with
in vivo experiments. Thus, reliance had to be
made on historical data, in some cases
recorded more than a year before commence-
ment of the mixture experiments, and this
placed great emphasis on the reproducibility
of test outcomes. We considered that the high
demands in terms of data variation were more
likely to be met with developmental end
points that lend themselves to straight-for-
ward quantification. For these reasons, we
selected changes in AGD and NR in male off-
spring of rats as main end points for our mix-
ture experiments. Both these end points are
sensitive to anti-androgen exposure.
The aim of our studies was to assess
whether the joint effects of mixtures of AR
antagonists can be predicted accurately over a
large effect range on the basis of dose–response
data of the individual components. We rea-
soned that if there are demonstrable consistent
relationships between the potency of individ-
ual chemicals and the ways in which they act
together, powerful tools for prospective risk
assessment would become available. These
tools could open the way to make productive
use of existing single-chemical databases for
the prediction of mixture effects. A second
aim was to determine whether there would be
joint effects when every mixture component
was present at doses that individually do not
produce observable responses.
Materials and Methods
Chemicals. The chemicals used were vinclo-
zolin (CAS No. 50471-44-8, purity 99%,
ChemService catalogue no. PS-1049; Bie &
Berntsen, Herlev, Denmark), procymidone
(CAS No. 32809-16-8, purity 99%, Chem-
Service catalogue no. PS-2126; Bie &
Berntsen), ﬂutamide (CAS No. 13311-84-7,
purity 99%, catalogue no. F9397; Sigma
Aldrich, Brønby, Denmark), and corn oil
used as vehicle (Bie & Berntsen).
Studies and dose levels. Before the mixture
experiment, dose–response studies for each
chemical were conducted. The dose ranges
were chosen with the aim to cover the entire
range of effects from no effect up to maximum
effects, as determined by measurement of
AGD and NR. At the same time, it was
attempted to select doses that would not cause
marked effects on body weights in the dams,
and especially in the offspring, as this would
complicate evaluation of the effects on AGD
and NR. The dose levels selected for the
dose–response studies were based on the
reductions of AGD and increase of NR
reported for vinclozolin (Gray et al. 1994,
1999; Hellwig et al. 2000; Hotchkiss et al.
2002; Shimamura et al. 2002), flutamide
(Foster and McIntyre 2002; Hib and Ponzio
1995; Hotchkiss AK et al. 2002; McIntyre
et al. 2001; Miyata et al. 2002), and procymi-
done (Ostby et al. 1999). As data on procymi-
done were relatively limited, a range-finding
study was performed before the dose–response
study. To gain information about variability
of effects between studies, we ran selected
doses of vinclozolin, ﬂutamide, and procymi-
done in parallel with the mixture experiment.
An overview of the studies including dose
levels and number of animals is shown in
Table 1. A similar study design was used for
all studies (see below).
For the mixture study, a master mixture
was prepared by combining doses of vinclo-
zolin, flutamide, and procymidone that all
induced a half-maximal degree of NR (six nip-
ples) in male offspring. This approach was cho-
sen to avoid one single chemical contributing
disproportionately to the overall mixture effect.
The resulting mixture ratio of vinclozolin, ﬂu-
tamide, and procymidone was 31:1:18 based
on weight (Table 2), and the master mixture
contained 22,026 mg vinclozolin, 696.6 mg
flutamide, and 12,675 mg procymidon in
600 mL corn oil. It was diluted into ﬁve doses
of the mixture (1:14, 1:5, 1:2, 6:4, and 9:1).
These dose levels were chosen with the aim of
covering the entire dose–response curve. 
Animals and dosing. The animals were
treated humanely and with regard for alleviation
of suffering. The studies were performed under
conditions approved by the Danish Agency for
Protection of Experimental Animals and by the
inhouse Animal Welfare Committee. 
Time-mated nulliparous, young adult
Wistar rats (HanTac:WH, Taconic Europe,
Ejby, Denmark; body weight approximately
200 g) were supplied at day 3 of pregnancy.
The day after mating was designated gestational
day (GD) 1, and postnatal day (PND) 0 was
the day of birth. On the day after arrival
(GD4), the dams were distributed pseudoran-
domly into groups of 16 or 8 animals with sim-
ilar body weight (bw) distributions. They were
housed in pairs until GD21 and alone there-
after under standard conditions in semitrans-
parent plastic cages (15 × 27 × 43 cm) with
Aspen bedding (Tapvei, Gentofte, Denmark)
situated in an animal room with controlled
environmental conditions (12-hr light–dark
cycles with light starting at 2100 hours, light
intensity 500 lux, temperature 21 ± 2°C,
humidity 50% ± 5%, ventilation eight air
changes per hour). A complete rodent diet for
growing animals ALTROMIN 1314 (soy- and
alfalfa-free; ALTROMIN GmbH, Lage,
Germany) and acidiﬁed tap water (to prevent
microbial growth) were provided ad libitum. 
Test chemicals and mixtures were admin-
istered by gavage from GD7 to the day
before expected birth (GD21) and from
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Table 1. Studies, groups, doses, and number of time-mated animals per group.
No. of animals
Study Groups and doses per group
1. Vinclozolin and ﬂutamide,  Control: vehicle-dosed  16
dose–response 6 doses of vinclozolin: 5, 10, 20, 40, 80, or 160 mg/kg/day  8
6 doses of ﬂutamide: 0.5, 1.0, 2.0, 4.0, 8.0, or 16 mg/kg/day 8
2. Procymidone, range-ﬁnding Control: vehicle-dosed 16
2 doses of procymidone: 25 or 200 mg/kg/day 4
3. Procymidone, dose–response Control: vehicle-dosed 16
6 doses of procymidone: 5, 10, 25, 50, 100, or 150 mg/kg/day 8
4. Mixture study of vinclozolin,  Control: vehicle-dosed 16
ﬂutamide, and procymidone 5 doses of mixture: 7.87, 19.67, 39.33, 70.80, or 106.19 mg/kg/day 16
2 doses of vinclozolin: 24.5 or 95.9 mg/kg/day 16
2 doses of ﬂutamide: 0.77 or 3.86 mg/kg/day 8
2 doses of procymidone: 14.1 or 61.8 mg/kg/day 8
Anti-androgen mixture: AGD and nipple retentionPND1 until PND16. The dosing volume of
2 mL/kg bw was calculated on the basis of
the body weight of the animal on the day of
dosing. The dose levels and group sizes are
shown in Table 1. Animals were inspected
for general toxicity twice daily. The studies
were performed using four blocks (with
1 week in between), and all dose groups were
equally represented in the blocks. 
Anogenital distance and nipple retention.
In all studies, AGD and NR were recorded by
the same technician who was blinded with
respect to exposure groups. After birth all live
pups in the litter were weighed, sexed, and
AGD was measured using a stereomicroscope.
The sex of several of the pups in the highest
dose groups could not be determined based on
the AGD, as the AGDs were similar to female
values in all pups in some litters. In these cases,
the sex of the pups was determined later by
internal inspection of reproductive organs with
the presence of testes defining a male. The
highest AGD values obtained in the litter were
used as the values for male pups. This
approach was chosen because these values were
most likely to represent the males, as males
normally have longer AGDs than females. For
dose–response analysis, AGD data were ana-
lyzed by the calculated AGD-index, namely,
AGD divided by the cube root of body weight.
The cube root was used because this converts a
three-dimensional end point (weight) into a
one-dimensional such as the AGD (Gray et al.
1999; Robert et al. 1999). This ratio assumes
that the relationship between AGD and trans-
formed body weight is directly proportional
and linear. To assess the validity of this
assumption, we explored using the transformed
body weight as a co-variable in statistical analy-
ses. However, we did not detect any relevant
difference between these two approaches, and
in the interest of keeping the model parameters
low, we decided to base all statistical analyses
on the AGD index. 
The body weights of all pups were
recorded on PND 12 ± 1, together with the
number of nipples/areolas, defined as a dark
focal area (with or without a nipple bud)
located where nipples are normally present in
female offspring. Females normally have 12
nipples, but may in a few cases show up to 14. 
Data normalizations and dose–response
analysis. Slight differences in absolute control
values between studies were controlled for by
standardizing the absolute AGD indices to rel-
ative values between one (no effect on male
AGD index) and zero (complete feminiza-
tion). The mean AGD indices from unex-
posed male and female pups were used to
deﬁne the minimum and maximum responses,
respectively. Regression analyses were based on
normalized AGD indices. In contrast, absolute
AGD indices were used for estimations of no
observed adverse effect levels (NOAELs).
Because NR is a quantal end point, data nor-
malization was not necessary in this case.
Statistical dose–response regression analy-
ses for both end points were carried out by
applying a best-fit approach (Scholze et al.
2001). Various nonlinear regression models
(logit, probit Weibull, generalized logit),
which all describe monotonic sigmoidal dose-
response relationships, were fitted indepen-
dently to the same data set and the best-ﬁtting
model was selected on the basis of a statistical
goodness-of-ﬁt criterion, the information cri-
terion of Schwarz (1978).
To control for litter effects on AGD,
dose–response data for the normalized AGD
indices were analyzed by a generalized nonlin-
ear mixed-model approach (Vonesh and
Chinchilli 1996), with the litter as a random
effect modiﬁer for individual AGD data.
To take account of uncertainties in the
mean control estimates for AGD during the
scaling of effects, we included an upper and
lower asymptote in the regression models.
However, neither for the individual com-
pounds nor for the mixture were the resulting
model parameters signiﬁcantly different from 0
and 1, respectively. To avoid overparameteriza-
tion, upper and lower asymptotes were there-
fore not estimated, but instead set a priori to 0
and 1 (see θmax = 1 in Table 2). Statistical
analyses of AGD data were carried out using
the SAS procedure PROC NLMIXED (SAS
Institute Inc., Cary, NC, USA). 
The number of nipples/areolas was
assumed to follow a binomial distribution
with a response range between 0 and θmax,
with θmax being equal to the biologically possi-
ble maximal number of nipples in rats, either
12 or 13 (Table 2). The choice of θmax was
decided on considering the global ﬁt (informa-
tion criterion of Schwarz). To account for lit-
ter effects on NR, correlation structures
between number of nipples/areolas and litter
were modeled by the generalized estimating
equations method (Vonesh and Chinchilli
1996). All statistical analysis was performed
using the SAS procedure PROC GENMOD
(SAS Institute, Inc., Cary, NC, USA).
The analyses for single compounds were
carried out using effect data pooled from the
initial dose–response studies (Table 1, stud-
ies 1–3) and the repeat experiments run con-
currently with the mixture study (Table 1,
study 4). “Study run” was implemented as an
additional model factor in data analysis. The
effect doses (EDx) shown in Table 2 were
selected for low and median response levels and
were calculated from the functional inverse of
the best-ﬁtting model. Statistical uncertainties
for the estimated effect doses were expressed as
95% conﬁdence belts and approximately deter-
mined by applying the bootstrap method
(Efron and Tibshirani 1993).
NOAELs were estimated using multiple
contrast tests (Hothorn 2004). These tests
were chosen as they are already implemented
in the SAS procedures PROC NLMIXED and
PROC GENMOD. Corresponding optimal
contrasts were determined according to the
best-ﬁt regression model (Bretz et al. 2005).
Calculation of mixture–effect predictions
using dose addition. To assess whether the
joint effect of the three chemicals was dose
additive, we predicted mixture effects based on
information about the dose–effect relationships
of all individual mixture components. These
data were derived from the best-ﬁt regression
Hass et al.
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Table 2. Statistical dose–effect descriptors for single and mixture exposures.
Fraction in  Dose–response function Effect doses (mg/kg/day) NOAELa
Substance mixtureb RMc θ ˆ
1 θ ˆ
2 θ ˆ
3 θ ˆ
max Medium Low (mg/kg/day)
Nipple retention ED6
d (95% CI) ED1
d (95% CI)
Vinclozolin 0.622301 BP-probit –1.76 0.025 1.024 12 67.18 (55.78–77.08) 5.73 (0.67–25.58) < 5.0
Flutamide 0.019558 Probit –0.61 2.01 — 12 2.02 (1.71–2.40) 0.41 (0.28–0.60) < 0.5
Procymidon 0.358141 BP-logit –5.09 1.21 0.1 12 33.91 (24.81–45.74) 7.51 (> 0.1–10.76) 10.0
Mixture bw-Weibull –19.66 16.83 –0.8 13 20.78 (17.76–23.52)  8.21 (6.67–10.42) < 7.87
AGD index ED50
e (95% CI) ED90
e (95% CI)
Vinclozolin 0.622301 Logit –6.80 3.59 — 1 78.65 (67.43–93.32) 9.21 (11.57–29.08) 5.0
Flutamide 0.019558 Weibull –1.38 1.85 — 1 3.54 (2.84–4.37) 0.34 (0.19–0.57) < 0.5
Procymidon 0.358141 bw-Weibull  –6.31 2.087 –0.20 1 69.38 (56.69–86.38) 1.84 (4.12–22.47) 10.0
Mixture Glogit II –9.24 7.21 0.29 1 39.77 (32.51–49.48) 4.68 (6.79–20.73) 19.67
aNOAEL – no observed adverse effect level, marked as “<” when the lowest tested dose already produced a signiﬁcant effect. bRatio of the dose of each compound to total mixture dose.
cRM – regression models as deﬁned by Scholze et al. (2001); for more details see “Material and Methods”; θ ˆ
1, θ ˆ
3, θ ˆ
3,– statistical estimates of model parameters, given for doses expressed
as mg/kg/day (rounded values); θ ˆ
max– upper model asymptote. dED6, ED1 – effect doses for 6 and 1 nipples, calculated from the respective dose–response function. eED50,E D 90 – effect
doses for 50% and 90% normalized AGD index, calculated from the respective dose–response function; 95% CI – 95% conﬁdence intervals for mean effect doses given in mg/kg/day.functions (Table 2) and used to calculate the
expected responses of a mixture with deﬁned
mixture ratio over a large range of responses
(“fixed mixture ratio design”) (Faust et al.
2001). The choice of doses was based on the
concentration range described by the additiv-
ity prediction, which is defined for a multi-
component mixture of three components as
. [1]
Here, EDx1, EDx2, and EDx3 are the effect
doses of vinclozolin, ﬂutamide, and procymi-
don that on their own produce the same quan-
titative effect x as the mixture, and p1, p2, and
p3 are the relative proportions of the corre-
sponding individual doses present in the total
mixture dose (see Table 2, “Fraction in mix-
ture”). The individual effect doses were derived
from the dose–response functions for vinclo-
zolin, flutamide, and procymidone by using
their inverse functional form. Equation 1
allows calculation of any effect dose of a mix-
ture under the hypothesis of dose additivity,
provided the dose–response functions of all
mixture components and the mixture ratio are
known. Graphs of predicted mixture dose–
response curves (Figure 1) were obtained by
calculating numerous EDxmixture values, with x
varying from 10 to 90% for the normalized
AGD index and from 1 to 11 for nipples. The
statistical uncertainty for the predicted mix-
ture–effect doses EDxmixture was determined by
using the bootstrap method (Efron and
Tibshirani 1993) and expressed as 95% conﬁ-
dence intervals (CIs) for the predicted mean
estimate. Differences between predicted and
observed effect doses were deemed statistically
signiﬁcant when the 95% conﬁdence belts of
the prediction did not overlap with those of
the experimentally observed mixture effects.
Results
Pregnancy and litter data. No clinical signs
of general toxicity were observed during the
daily observations. The maternal body weight
gain from GD7 to PND1 was significantly
decreased (12.8 ± 14.6 g compared with 24.3 ±
9.4 g in the control group) in dams receiving
the highest dose of vinclozolin (160 mg/kg/
day), but none of the other doses of vinclozolin
provoked this effect. Pregnancy length, litter
sizes, birth weight of male and female off-
spring, and sex ratios in the litters remained
unaltered in all vinclozolin-dosed groups when
compared to controls. None of the tested doses
of flutamide induced reductions of maternal
weight gain, or other signs of maternal toxicity.
In the range-ﬁnding study with procymidone
(Table 1, study 2), litter sizes were markedly
decreased at the highest dose of 200 mg/kg/day.
The dose–response study (Table 1, study 3)
using 150 mg/kg/day as the highest dose did
not show effects on pregnancy length, litter
sizes, birth weights, or sex ratios in the litters.
Maternal body weight gain from GD7 to
PND1 was decreased in the dams exposed to
25 mg/kg/day procymidone and higher, but
no clear dose–response relationship was appar-
ent with these weight gain changes.
In dams exposed to the two highest doses
of the mixture of vinclozolin, ﬂutamide, and
procymidone (Table 1, study 4), maternal
body weight gain from GD7 to PND1 was
decreased. Among the groups of pregnant rats
that were dosed with the single agents in paral-
lel with the mixture experiment (Table 1,
study 4), those receiving the higher dose of
procymidone (61.8 mg/kg/day) also had
diminished weight gain. Decreased litter sizes
were observed at the high dose of flutamide
(3.86 mg/kg/day). As this was not found in the
previous dose–response study at the similar
dose level of 4 mg/kg/day, or at the higher
doses of 8 and 16 mg/kg/day, this is considered
a random ﬁnding unrelated to exposure to ﬂu-
tamide. None of the mixture doses caused sig-
niﬁcant effects on pregnancy length, litter sizes,
birth weights, and sex ratios in the litters. 
Effects of vinclozolin, flutamide, and
procymidone on AGD and NR. All chemicals
produced dose-dependent changes in AGD
index and NR and the resulting dose–response
curves were observed to be quite steep. The
entire effect range from control levels to maxi-
mal responses could be covered by dose
changes of only two orders of magnitude
(Figure 2). While vinclozolin and procymi-
done were of similar potency, flutamide was
effective at approximately 10-fold lower doses.
Compared with the AGD index, NR was
generally the more sensitive end point. At the
lowest tested doses of 5 and 0.5 mg/kg/day,
respectively, vinclozolin and ﬂutamide induced
statistically signiﬁcant changes in NR, whereas
the respective AGD indices did not differ sig-
niﬁcantly from those of controls at these doses.
NOAELs could therefore not be defined for
vinclozolin and ﬂutamide. For procymidone a
NOAEL of 10 mg/kg/day was estimated.
To gain an impression of variability
among studies, selected dose levels of all three
chemicals were retested in parallel with the
mixture experiment. The reproducibility of
effects observed in the earlier studies (Table 1,
studies 1–3) was generally good. At the lower
doses, the animals in the repeat studies were
slightly less responsive in terms of changes in
AGD index, but the NR effects tended to be
a little higher upon retesting (Figure 2;
Table 3). Table 2 summarizes key parameters
characterizing the dose–response relationships
of each single substance. Generally, our data
are in broad agreement with results published
by others (Foster and McIntyre 2002; Gray
et al. 1999; Hellwig et al. 2000; Hib and
Ponzio 1995; Hotchkiss et al. 2002; McIntyre
et al. 2001; Miyata et al. 2002; Ostby et al.
1999; Shimamura et al. 2002). However,
because of the unprecedented level of detail in
our dose–response analyses, more in-depth
comparisons are not possible. 
Combination effects of vinclozolin,
ﬂutamide, and procymidone. The mixture of
vinclozolin, ﬂutamide, and procymidone pro-
duced dose-dependent changes in AGD index
and NR (Figure 1). The NOAEL for changes
in AGD index was 19.67 mg/kg/day, but the
lowest tested mixture dose of 7.87 mg/kg/day
induced statistically signiﬁcant changes in NR
(Table 2). Therefore, the overall mixture
NOAEL is lower than 7.87 mg/kg/day. 
The dose–response data for the single
agents, pooled from all studies (Figure 2;
Table 2), were used to compute predicted
dose-additive combination effects covering
the entire range of effects (Figure 1, green
curves). For both end points, the anticipated
combination effects fell within the range of
the effects that were observed experimentally.
Numerical comparisons between predicted
and observed AGD index (Table 3) revealed
fairly good agreement. Despite the long period
that had elapsed between the recording of the
effects of the individual mixture components
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Figure 1. Effects of mixed exposure to vinclozolin, flutamide, and procymidone on AGD (A) and NR (B).
Results shown are group mean ± SE (red), litter means (black), mean dose–response curve ± 95% conﬁ-
dence belt based on regression analysis (blue) and mean predicted mixture effect ± 95% conﬁdence belt
(green). Dashed horizontal lines show male and female control values. See text for details. 
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Total mixture dose (mg/kg)and the mixture experiment itself, the
predicted effect doses in the median and high
effect ranges differed by only a factor of 1.3
from those experimentally observed. Whether
the anticipated combination effects were cal-
culated using the data from the concurrent
studies or using the pooled data sets including
the historical data had little inﬂuence on the
quality of the prediction. The joint effects of
vinclozolin, flutamide, and procymidone on
reductions of AGD in male rats were essen-
tially dose additive.
In contrast, the deviations between predic-
tion and observation were generally larger for
NR than for AGD index, with observed NR
responses exceeding the predicted mixture
effects (Table 3; Figure 1). The effect doses
predicted on the basis of the pooled single
agent data were higher than the observed mix-
ture–effect doses in the median- and high-
effect range (6 and 10 retained nipples/areolas).
This was not the case for the low-effect range
(1 retained nipple/areola). Predictions based on
the responses seen with single agents run in
parallel with the mixture study (Table 1,
study 4) produced lower effect doses in the
median- and high-effect range, in better agree-
ment with the observed results.
Mixture effects at low doses of individual
mixture components. Because the doses of the
single chemicals present in the mixture were
quite low, we assessed whether there were sig-
niﬁcant combination effects when all compo-
nents were present at doses that individually
did not induce observable effects. At a dose of
39.37 mg/kg/day, the mixture induced a
marked effect on the AGD index (around
50% reduction). This mixture contained
24.5 mg/kg/day vinclozolin, 0.77 mg/kg/day
ﬂutamide and 14.1 mg/kg/day procymidone,
and individually these doses did not induce
significant reductions in the AGD index
(Figure 3). With NR as the end point, the
single-chemical effects were small but statisti-
cally significant at these doses, whereas the
combined exposure induced a marked effect. 
Discussion
Previous work with anti-androgens has
focused mainly on events surrounding AR
binding and activation and has shown that
combinations of these chemicals are able to
act together in an additive fashion (Birkhoj
et al. 2004; Nellemann et al. 2003). These
studies have prepared the ground for address-
ing the question as to whether there are also
joint effects with responses further removed
from receptor binding and activation, such as
those related to male sexual differentiation.
For the first time, we have addressed this
question by using the fixed mixture ratio
approach for studying combination effects on
the disruption of male sexual development.
With reductions of AGD as the end
point, the experimentally observed mixture
effects were in good agreement with the dose
additivity expectation calculated on the basis
of the individual dose–response relationships
for vinclozolin, ﬂutamide, and procymidone.
Although the predicted mixture effects for
NR also fell within the limits of the lowest
experimentally recorded responses, the
Hass et al.
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Figure 2. Effects of vinclozolin (A,B), flutamide (C,D), and procymidone (E,F), given individually, on AGD
(left) and NR (right). Results shown are group mean ± SE (red), litter means from the dose–response stud-
ies (black), litter means from the single doses within mixture study (grey), and the mean dose–response
curve ± 95% conﬁdence belt based on regression analysis (blue). Dashed horizontal lines show male and
female control values. See text for details.
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Table 3. Statistical uncertainty of predicted and observed effect doses for the mixture of vinclozolin, ﬂu-
tamide, and procymidone.
Effect doses for the mixture (mg/kg/day)
Observeda Predicted by DApooled
b Predicted by DAconﬁrmation
c
Effect level [Mean (95% CI)] [Mean (95% CI)] [Mean (95% CI)]
Relative AGD index (%)
90 14.68 (6.79–20.73) 8.29 (5.06–11.17) 14.98 (4.22–19.80)
50 39.77 (32.51–49.48) 53.75 (48.22–60.34) 52.58 (44.17–75.98)
20 112.45 (77.79–184.51) 143.19 (113.05–193.54) 129.34 (100.67–204.49)
Number of nipples/areolas
1 8.21 (6.67–10.42) 7.43 (0.11–9.36) 7.45 (3.06–11.73)
6 20.78 (17.76–23.52) 33.88 (29.23–38.41) 27.98 (22.04–34.07)
10 45.33 (38.91–55.86) 73.66 (67.25–82.05) 57.31 (50.17–67.58)
aEffect doses as calculated from the dose–response functions given in Table 2. bDA, dose addition; predicted effect doses
are based on pooled data from studies 1–4 for vinclozolin, flutamide, and procymidone and were calculated from the
respective dose–response functions given in Table 2. cPredicted effect doses are based on data for vinclozolin, ﬂutamide,
and procymidone from study 4 only, where two doses each of these chemicals were run in parallel with the mixture
experiment. Predicted mixture–effect doses were estimated by linear regression (model estimates not shown).NR responses in the median and high end
indicated that the mixture was more potent
than predicted. The movement away from the
anticipated combination effects can be partly
attributed to the fact that the single agent
responses seen concurrently with the mixture
study were slightly higher than previously
recorded, particularly in the high-effect range.
When the mixture–effect prediction was based
solely on the data from the concurrently run
single agent studies, the differences between
anticipated and observed effect doses for NR
became smaller. This could indicate that the
animals used for the mixture experiment
showed subtle differences in their responses to
the anti-androgens compared with the rats
used for the earlier dose–response studies. The
reason such differences should have become
apparent only in terms of altered NR, but not
in relation to AGD, may lie partly in the
greater sensitivity of NR as an anti-androgenic
end point. However, other as yet unrecog-
nized factors may also have played a role. Seen
in this light, we hesitate to interpret the joint
effects of the mixture on NR as weakly syner-
gistic, although the numerical discrepancies
between observed and anticipated additive
effects would support such a conclusion.
Much larger studies would be required to
resolve conclusively whether vinclozolin, ﬂu-
tamide, and procymidone exhibit a weak
synergism with respect to NR. Nevertheless,
in view of the complexity of the events leading
to alterations in AGD and NR, and consider-
ing the experimental challenges in recording
such effects reliably and reproducibly over a
long period, we were surprised that the com-
bined effects of the three anti-androgens could
be predicted quite accurately. We therefore
conclude that the dose addition approach pro-
vides an excellent basis for prediction of the
joint effects of multicomponent mixtures of
similarly acting anti-androgens.
Although the primary aim of our work
was to assess the predictability of mixture
effects of anti-androgens, the results of our
study also allow assessments of the question as
to whether there are joint effects when all mix-
ture components are present at doses that
individually do not induce detectable effects.
This phenomenon, somewhat provocatively
dubbed “something from ‘nothing’” (Silva
et al. 2002), has been observed with multi-
component mixtures of estrogenic agents in
reporter-based assays (Rajapakse et al. 2002;
Silva et al. 2002), the uterotrophic assay
(Tinwell and Ashby 2004), and vitellogenin
induction in ﬁsh (Brian et al. 2005). The basis
of the something from nothing phenomenon
derives from the theoretical assumptions that
underlie the concept of dose addition.
According to dose addition, every agent at any
dose contributes, in proportion to its toxic
unit, to the overall effect of a mixture. Because
every mixture component can be replaced
totally or in part by an equal fraction of an
equi-effective dose of another, it does not mat-
ter whether the individual doses are also effec-
tive on their own. “Something from nothing”
effects should occur even when individual toxi-
cants are present at doses below effect thresh-
olds, provided sufficiently large numbers of
components sum up to a suitably high total-
effect dose.
The results shown in Figure 3 support the
idea that the “something from nothing” phe-
nomenon also applies to alterations in the
AGD of male rats exposed to anti-androgens
during development. In this case a com-
bination of 24.5 mg/kg/day vinclozolin,
0.77 mg/kg/day ﬂutamide and 14.1 mg/kg/day
procymidone induced half-maximal AGD
alterations, but the effects induced by each
chemical on its own did not reach statistical
significance when compared with effects in
untreated controls. However, whether the
doses of the chemicals present in the mixture
were indeed equivalent to nothing in the sense
of zero effect levels is debatable. Regression
analysis of the dose–response data for the three
chemicals (Figure 2) showed that the effects
associated with these doses were between 5
and 10% of a biologically possible maximal
effect. In addition, in the earlier dose–response
study, vinclozolin actually induced a signifi-
cant effect on AGD at a lower dose than the
24.5 mg/kg/day present in the mixture.
Generally, these results show that lack of sta-
tistical signiﬁcance cannot be equated with an
absence of biological effects. 
Because of the apparently greater sensitiv-
ity of NR as an anti-androgenic end point,
the something from nothing effect could
not be evaluated with a combination of
24.5 mg/kg/day vinclozolin, 0.77 mg/kg/day
ﬂutamide and 14.1 mg/kg/day procymidone,
because the individual doses induced NR
that clearly reached statistical significance
(Figure 3). The results, however, illustrate
something not too dissimilar from the some-
thing from nothing phenomenon, which could
be called “marked effects from small effects”:
The mixture-induced NR approaching com-
plete feminization of the males, whereas the
individual doses caused only modest effects. In
general, our ﬁndings do not contradict theoreti-
cal expectations and are consistent with the ear-
lier observations made with mixtures of
estrogenic chemicals (Brian et al. 2005;
Rajapakse et al. 2002; Silva et al. 2002; Tinwell
and Ashby 2004). The something from noth-
ing phenomenon would most probably have
been demonstrated also with NR as the end
point, had lower doses been employed or had
more mixture components been combined.
In conclusion, our results show that com-
binations of similarly acting anti-androgens
are able to produce developmental effects in
male offspring of rats. These effects can be
predicted fairly accurately on the basis of
information about the potency of the individ-
ual mixture components by using the dose
addition concept. There are indications that
anti-androgens act together to produce
marked joint effects when combined at doses
that individually produce small, statistically
insignificant responses. The significance of
these ﬁndings for human and environmental
risk assessment cannot be overstated; doses of
endocrine-active chemicals, which appear to
exert only small effects when judged on their
own, may induce marked responses when
they act in concert with numerous, possibly
unrecognized, similarly acting agents.
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Figure 3. Mixture effects on AGD (A) and NR (B) at low doses of individual mixture components. Results
shown are group mean ± 95% confidence belt for control males and females (gray), individual doses of
24.5 mg/kg vinclozolin (VZ), 0.77 mg/kg flutamide (FLUT), and 14.1 mg/kg prycymidone (PRO) (blue), the
combined mixture dose of 39.37 mg/kg (blue), and the predicted mixture effect (white). Open circles repre-
sent litter means.
*p < 0.05 compared to control. 
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